Haleon PLC 6-K Filing
Ticker: HLN · Form: 6-K · Filed: Apr 1, 2026 · CIK: 0001900304
Sentiment: neutral
Filing Stats: 440 words · 2 min read · ~1 pages · Grade level 13.3 · Accepted 2026-04-01 08:16:43
Filing Documents
- a0320z.htm (6-K) — 20KB
- a0320z000.jpg (GRAPHIC) — 3KB
- 0001654954-26-003135.txt ( ) — 26KB
From the Filing
VOTING RIGHTS AND CAPITAL a0320z UNITED STATES   SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549     FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of April 2026   Commission File Number: 001-41411   Haleon plc (Translation of registrant’s name into English)   Building 5, First Floor, The Heights, Weybridge, Surrey, KT13 0NY (Address of principal executive offices)     Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:     Form 20-F ☒   Form 40-F ☐       EXHIBIT INDEX   Exhibit Number Description 99.1 01 April 2026 - “Total Voting Rights and Capital”       99.1       Haleon plc: Total Voting Rights and Capital   01 April 2026:   As at 31 March 2026 the total number of shares issued by Haleon plc ("Haleon" or the "Company") is   8,931,093,261   ordinary shares of £0.01 each, of which   12,548,735   are held as treasury shares.   Therefore, the number of ordinary shares with voting rights is   8,918,544,526   and this figure should be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.   Notifiable interests in Haleon may be sent to:   company.secretary@haleon.com   Amanda Mellor Company Secretary   About Haleon Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as  Advil ,  Centrum ,  Otrivin ,  Panadol ,  parodontax ,  Polident ,  Sensodyne ,  Theraflu  and  Voltaren  - are trusted by more than one billion consumers and are recommended by health professionals around the world.   For more information, please visit   www.haleon.com .        SIGNATURE       Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.       HALEON PLC (Registrant)   Date: April 01, 2026 By: /s/ Amanda Mellor     Name: Amanda Mellor     Title: Company Secretary